Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_assertion type Assertion NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_head.
- NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_assertion description "[Targeting the PI3K/AKT/pathway with small molecule inhibitors in combination with chemotherapy could be exploited as a novel strategy in the treatment of liposarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_provenance.
- NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_assertion evidence source_evidence_literature NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_provenance.
- NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_assertion SIO_000772 24695632 NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_provenance.
- NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_assertion wasDerivedFrom befree-20150227 NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_provenance.
- NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_assertion wasGeneratedBy ECO_0000203 NP623806.RAwMjlfimmOTn6p0MzWQH0dayUgHJCfvNFcj0Ou-GIZA8130_provenance.